Agios Pharmaceuticals Inc. buy Bank of America Co.
Start price
24.12.25
/
50%
€23.80
Target price
24.12.26
€28.80
Performance (%)
-2.52%
Price
29.01.26
€23.20
Summary
This prediction is currently active. With a performance of -2.52%, the BUY prediction for Agios Pharmaceuticals Inc. by Bank_of_America_Co_ is down slightly. This prediction currently runs until 24.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | -4.132% | -4.132% |
| iShares Core DAX® | -1.432% | 0.000% |
| iShares Nasdaq 100 | -0.386% | -0.595% |
| iShares Nikkei 225® | 1.448% | 5.269% |
| iShares S&P 500 | 0.114% | -0.217% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at Bank of America Corporation from $32.00 to $34.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.00
20.11.25
20.11.25
€27.77
20.11.26
20.11.26
16.00%
29.01.26
29.01.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€33.80
22.07.25
22.07.25
€43.63
22.07.26
22.07.26
-31.95%
29.01.26
29.01.26